SCHEMBL27736388

SCHEMBL27736388

C=CC1(Nc2ncnc3ccc(I)cc23)C=CC=CC1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NCOA1 Q15788 1/20 0.35
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ EGFR P00533 5/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ FYN P06241 2/20 0.31
▸ SRC P12931 2/20 0.31
▸ FLT1 P17948 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27306975 0.80 SMN1; SMN2 (0.41) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL29133752 0.77 HTT (0.36) LMNAHTTEGFRIRAK4FLT1
SCHEMBL29133735 0.77 HTT (0.36) LMNAHTTEGFRIRAK4FLT1
SCHEMBL27697478 0.70 KDM4E (0.47) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL27850019 0.70 EGFR (0.48) EGFR
SCHEMBL7804103 0.66 CYP1A2 (0.54) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL29133739 0.64 HTT (0.50) KDM4EALDH1A1LMNAHPGDMTOR
SCHEMBL29133745 0.64 HTT (0.50) KDM4EALDH1A1LMNAHPGDMTOR
SCHEMBL1584864 0.64 IRAK4 (0.62) ALDH1A1LMNAIRAK4
SCHEMBL17732838 0.63 PARP1 (0.45) KDM4EALDH1A1LMNAHPGDMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101367794-B Preparation method for quinazoline derivants and medical uses thereof SHANGHAI HENGRUI PHARM CO LTD 2013-07-10 — — CN disclosed
CN-101367794-A Preparation method for quinazoline derivants and medical uses thereof SHANGHAI HENGRUI PHARM CO LTD (CN) 2009-02-18 — — CN disclosed
Send feedback